Literature DB >> 7537820

The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat.

L Chen1, Y Gu, L Y Huang.   

Abstract

1. The actions of dynorphin on N-methyl-D-aspartate (NMDA) responses were examined in acutely dissociated trigeminal neurons in rat. Whole-cell and single-channel currents were recorded using the patch clamp technique. 2. Dynorphins reduced NMDA-activated currents (INMDA). The IC50 was 0.25 microM for dynorphin (1-32), 1.65 microM for dynorphin (1-17) and 1.8 microM for dynorphin (1-13). 3. The blocking action of dynorphin is voltage independent. 4. The inhibitory action of dynorphin cannot be blocked by high concentration of the non-selective opioid receptor antagonist naloxone, nor by the specific kappa-opioid receptor antagonist nor-Binaltorphimine (nor-BNI). 5. Single-channel analyses indicate that dynorphin reduces the fraction of time the channel is open without altering the channel conductance. 6. We propose that dynorphin acts directly on NMDA receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537820      PMCID: PMC1157783          DOI: 10.1113/jphysiol.1995.sp020541

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  17 in total

1.  Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation.

Authors:  A H Dickenson; A F Sullivan
Journal:  Neuropharmacology       Date:  1987-08       Impact factor: 5.250

2.  Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat.

Authors:  S N Davies; D Lodge
Journal:  Brain Res       Date:  1987-10-27       Impact factor: 3.252

Review 3.  Anatomy of CNS opioid receptors.

Authors:  A Mansour; H Khachaturian; M E Lewis; H Akil; S J Watson
Journal:  Trends Neurosci       Date:  1988-07       Impact factor: 13.837

4.  Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines.

Authors:  O H Viveros; E J Diliberto; E Hazum; K J Chang
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

5.  Differential activation of spinal cord dynorphin and enkephalin neurons during hyperalgesia: evidence using cDNA hybridization.

Authors:  M J Iadarola; J Douglass; O Civelli; J R Naranjo
Journal:  Brain Res       Date:  1988-07-12       Impact factor: 3.252

6.  Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.

Authors:  J J Wagner; G W Terman; C Chavkin
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

7.  Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.

Authors:  J A Clark; L Liu; M Price; B Hersh; M Edelson; G W Pasternak
Journal:  J Pharmacol Exp Ther       Date:  1989-11       Impact factor: 4.030

8.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones.

Authors:  M L Mayer; G L Westbrook; P B Guthrie
Journal:  Nature       Date:  1984 May 17-23       Impact factor: 49.962

9.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

10.  Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.

Authors:  H C Moises; J M Walker
Journal:  Eur J Pharmacol       Date:  1985-01-15       Impact factor: 4.432

View more
  10 in total

1.  Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.

Authors:  Maia Terashvili; Hsiang-En Wu; Emma Schwasinger; Leon F Tseng
Journal:  Eur J Pharmacol       Date:  2006-10-17       Impact factor: 4.432

Review 2.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

3.  Mechanism and site of action of big dynorphin on ASIC1a.

Authors:  Christian B Borg; Nina Braun; Stephanie A Heusser; Yasmin Bay; Daniel Weis; Iacopo Galleano; Camilla Lund; Weihua Tian; Linda M Haugaard-Kedström; Eric P Bennett; Timothy Lynagh; Kristian Strømgaard; Jacob Andersen; Stephan A Pless
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-12       Impact factor: 11.205

4.  Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig.

Authors:  P E Castillo; P A Salin; M G Weisskopf; R A Nicoll
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

5.  Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.

Authors:  S F Traynelis; M F Burgess; F Zheng; P Lyuboslavsky; J L Powers
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.

Authors:  K F Hauser; J K Foldes; C S Turbek
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

7.  mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons.

Authors:  G Martin; Z Nie; G R Siggins
Journal:  J Neurosci       Date:  1997-01-01       Impact factor: 6.167

Review 8.  Pronociceptive actions of dynorphin via bradykinin receptors.

Authors:  Josephine Lai; Miaw-chyi Luo; Qingmin Chen; Frank Porreca
Journal:  Neurosci Lett       Date:  2008-04-08       Impact factor: 3.046

9.  Dynorphin opioid peptides enhance acid-sensing ion channel 1a activity and acidosis-induced neuronal death.

Authors:  Thomas W Sherwood; Candice C Askwith
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

10.  Dynorphin A (1-17) induces apoptosis in striatal neurons in vitro through alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor-mediated cytochrome c release and caspase-3 activation.

Authors:  I N Singh; R J Goody; S M Goebel; K M Martin; P E Knapp; Z Marinova; D Hirschberg; T Yakovleva; T Bergman; G Bakalkin; K F Hauser
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.